Open Forum Infect Dis. 2026 Jul 6;13(7):ofag398. doi: 10.1093/ofid/ofag398. eCollection 2026 Jul.
ABSTRACT
A substantial proportion of people with HIV and established atherosclerotic cardiovascular disease (ASCVD) meet criteria for extreme cardiovascular risk, yet low-density lipoprotein cholesterol (LDL-C) target achievement remains markedly suboptimal. Bridging the gap between updated guideline recommendations and real-world practice is essential to reduce recurrent ASCVD in this high-risk population.
PMID:42428772 | PMC:PMC13346108 | DOI:10.1093/ofid/ofag398